Assessment of the knowledge, preferences and concern regarding the prospective COVID-19 vaccine among adults residing in New Delhi, India - A cross-sectional study.
COVID-19
India
New Delhi
vaccine acceptance
Journal
Journal of family medicine and primary care
ISSN: 2249-4863
Titre abrégé: J Family Med Prim Care
Pays: India
ID NLM: 101610082
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
10
12
2020
revised:
21
02
2021
accepted:
03
05
2021
entrez:
29
7
2021
pubmed:
30
7
2021
medline:
30
7
2021
Statut:
ppublish
Résumé
Understanding the perception and concerns of people about COVID-19 vaccine in developing and populous country like India will help in understanding demand for the vaccine and further tailoring out public health information and education activities. The study was carried out to assess the present state of knowledge people have about the probable vaccine for COVID-19, to know the preferences of respondents about this vaccine and to learn the expectations and apprehensions of people about features of this prospective COVID-19 vaccine residing in the capital city of India. This cross-sectional study was conducted amongst the residents of Delhi, India from July to October 2020. Both offline and online interview method was used to collect date from 513 participants representing various occupational strata. Data were collected on sociodemographic variable, vaccine acceptance and concerns regarding COVID-19 vaccine. Among the study population, 79.5% said they will take the vaccine while 8.8% said they were not going to take the vaccine and remaining 11.7% had not yet decided about it. More than 50% were willing to pay for the vaccine and 72% felt vaccine should first be given to health workers and high-risk group. The following study has helped to understand the percentage of people who are hesitant to take the vaccine and also the concerns regarding the vaccine. Also since half of the population is willing to pay for the vaccine, a strategic approach considering the various economical classes of people could be applied in a developing country like India.
Sections du résumé
BACKGROUND
BACKGROUND
Understanding the perception and concerns of people about COVID-19 vaccine in developing and populous country like India will help in understanding demand for the vaccine and further tailoring out public health information and education activities. The study was carried out to assess the present state of knowledge people have about the probable vaccine for COVID-19, to know the preferences of respondents about this vaccine and to learn the expectations and apprehensions of people about features of this prospective COVID-19 vaccine residing in the capital city of India.
METHODS
METHODS
This cross-sectional study was conducted amongst the residents of Delhi, India from July to October 2020. Both offline and online interview method was used to collect date from 513 participants representing various occupational strata. Data were collected on sociodemographic variable, vaccine acceptance and concerns regarding COVID-19 vaccine.
RESULTS
RESULTS
Among the study population, 79.5% said they will take the vaccine while 8.8% said they were not going to take the vaccine and remaining 11.7% had not yet decided about it. More than 50% were willing to pay for the vaccine and 72% felt vaccine should first be given to health workers and high-risk group.
CONCLUSION
CONCLUSIONS
The following study has helped to understand the percentage of people who are hesitant to take the vaccine and also the concerns regarding the vaccine. Also since half of the population is willing to pay for the vaccine, a strategic approach considering the various economical classes of people could be applied in a developing country like India.
Identifiants
pubmed: 34322440
doi: 10.4103/jfmpc.jfmpc_2437_20
pii: JFMPC-10-2369
pmc: PMC8284199
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2369-2375Informations de copyright
Copyright: © 2021 Journal of Family Medicine and Primary Care.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
BMJ Glob Health. 2020 Nov;5(11):
pubmed: 33187963
Hum Vaccin Immunother. 2020 Dec 1;16(12):3074-3080
pubmed: 32991230
EClinicalMedicine. 2020 Sep;26:100495
pubmed: 32838242
Soc Sci Med. 2020 Nov;265:113414
pubmed: 33038683
Front Public Health. 2020 Jul 14;8:381
pubmed: 32760691
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
J Multidiscip Healthc. 2020 Nov 20;13:1657-1663
pubmed: 33262600
Eur J Health Econ. 2020 Sep;21(7):977-982
pubmed: 32591957
Soc Sci Med. 1999 Dec;49(12):1705-16
pubmed: 10574240
J Community Health. 2021 Jun;46(3):457-470
pubmed: 32638198
Nature. 2020 Nov;587(7834):337-338
pubmed: 33199901
Hum Vaccin Immunother. 2017 Apr 3;13(4):786-790
pubmed: 27905832
Lancet Digit Health. 2020 Oct;2(10):e504-e505
pubmed: 32984795
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Science. 2020 Aug 14;369(6505):749
pubmed: 32792371